DIVA Laboratories, Ltd. (TPEX:4153)
42.10
-0.15 (-0.36%)
Apr 24, 2025, 1:30 PM CST
DIVA Laboratories Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 589.14 | 536.93 | 346.37 | 299.28 | 323.76 | Upgrade
|
Trading Asset Securities | - | - | - | - | 3.92 | Upgrade
|
Cash & Short-Term Investments | 589.14 | 536.93 | 346.37 | 299.28 | 327.67 | Upgrade
|
Cash Growth | 9.72% | 55.02% | 15.73% | -8.67% | -41.55% | Upgrade
|
Accounts Receivable | 262.41 | 203.13 | 281.89 | 190.37 | 188.14 | Upgrade
|
Other Receivables | 23.45 | 10.08 | 19.55 | 13.31 | 8.2 | Upgrade
|
Receivables | 285.86 | 213.2 | 301.44 | 203.68 | 196.35 | Upgrade
|
Inventory | 151.42 | 196.21 | 319.3 | 352.32 | 250.19 | Upgrade
|
Prepaid Expenses | 3.88 | 4.86 | 8.42 | 11.5 | 11.78 | Upgrade
|
Other Current Assets | 0.75 | 5.21 | 0.86 | 7.8 | 5.55 | Upgrade
|
Total Current Assets | 1,031 | 956.41 | 976.39 | 874.57 | 791.53 | Upgrade
|
Property, Plant & Equipment | 222.96 | 231.46 | 225.57 | 227.56 | 232.92 | Upgrade
|
Long-Term Investments | 5.03 | 4.61 | 6.32 | 30.94 | 35.45 | Upgrade
|
Goodwill | - | - | - | 5.18 | 5.18 | Upgrade
|
Other Intangible Assets | 1.71 | 0.74 | 1.31 | 4.41 | 6.91 | Upgrade
|
Long-Term Deferred Tax Assets | 40.76 | 47.33 | 38.27 | 36.08 | 35.52 | Upgrade
|
Other Long-Term Assets | 3.92 | 3.19 | 3.94 | 2.94 | 5.71 | Upgrade
|
Total Assets | 1,305 | 1,244 | 1,252 | 1,182 | 1,113 | Upgrade
|
Accounts Payable | 70.69 | 61.07 | 85.15 | 103.88 | 46.41 | Upgrade
|
Accrued Expenses | 74.97 | 65.11 | 67.2 | 45.6 | 35.28 | Upgrade
|
Current Portion of Leases | 2.47 | 2.53 | 0.13 | 0.13 | 0.13 | Upgrade
|
Current Income Taxes Payable | 23.32 | 22.02 | 24.35 | 5.75 | 8.03 | Upgrade
|
Current Unearned Revenue | 6.51 | 9.11 | 8.81 | 6.2 | 5.6 | Upgrade
|
Other Current Liabilities | 68.95 | 43.47 | 48.95 | 30.72 | 27.28 | Upgrade
|
Total Current Liabilities | 246.92 | 203.31 | 234.59 | 192.27 | 122.72 | Upgrade
|
Long-Term Leases | 2.5 | 4.97 | 0.15 | 0.28 | 0.41 | Upgrade
|
Long-Term Deferred Tax Liabilities | 0.43 | 0.87 | - | 0.02 | 0.3 | Upgrade
|
Other Long-Term Liabilities | 0.1 | 1.59 | - | - | - | Upgrade
|
Total Liabilities | 249.94 | 210.93 | 235.62 | 195.27 | 124.34 | Upgrade
|
Common Stock | 600.91 | 600.91 | 617.59 | 617.59 | 617.59 | Upgrade
|
Additional Paid-In Capital | 382.33 | 393.58 | 400 | 400 | 400 | Upgrade
|
Retained Earnings | 124.06 | 92.02 | 107.76 | 78.75 | 73.95 | Upgrade
|
Treasury Stock | -45.99 | -45.99 | -99.91 | -99.91 | -99.91 | Upgrade
|
Comprehensive Income & Other | -5.8 | -7.72 | -9.26 | -10 | -2.74 | Upgrade
|
Total Common Equity | 1,056 | 1,033 | 1,016 | 986.42 | 988.89 | Upgrade
|
Shareholders' Equity | 1,056 | 1,033 | 1,016 | 986.42 | 988.89 | Upgrade
|
Total Liabilities & Equity | 1,305 | 1,244 | 1,252 | 1,182 | 1,113 | Upgrade
|
Total Debt | 4.97 | 7.51 | 0.28 | 0.41 | 0.54 | Upgrade
|
Net Cash (Debt) | 584.17 | 529.42 | 346.08 | 298.86 | 327.13 | Upgrade
|
Net Cash Growth | 10.34% | 52.98% | 15.80% | -8.64% | -41.65% | Upgrade
|
Net Cash Per Share | 9.91 | 8.99 | 5.88 | 5.08 | 4.91 | Upgrade
|
Filing Date Shares Outstanding | 58.67 | 58.67 | 58.67 | 58.67 | 58.67 | Upgrade
|
Total Common Shares Outstanding | 58.67 | 58.67 | 58.67 | 58.67 | 58.67 | Upgrade
|
Working Capital | 784.13 | 753.1 | 741.8 | 682.3 | 668.81 | Upgrade
|
Book Value Per Share | 17.99 | 17.60 | 17.32 | 16.81 | 16.86 | Upgrade
|
Tangible Book Value | 1,054 | 1,032 | 1,015 | 976.83 | 976.8 | Upgrade
|
Tangible Book Value Per Share | 17.96 | 17.59 | 17.30 | 16.65 | 16.65 | Upgrade
|
Land | 154.92 | 154.92 | 154.92 | 154.92 | 154.92 | Upgrade
|
Buildings | 85.42 | 85.42 | 85.42 | 85.42 | 85.42 | Upgrade
|
Machinery | 91.36 | 90.79 | 86.84 | 84.46 | 83.14 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.